Anupam Dalal
Director · Whitehawk Therapeutics, Inc.
- 2026
- Jul 30, 2026
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Anupam Dalal files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- David James Lennon - $1.06M in WHWK purchases and sales in the last 12 months
- Scott M. Giacobello - $891K in WHWK purchases and sales in the last 12 months
- Bryan Ball - $635K in WHWK purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Anupam Dalal?
Anupam Dalal is a corporate insider, tracked as Director of Whitehawk Therapeutics, Inc. (WHWK). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Anupam Dalal last file a Form 4?
The only primary Form 4 on record is dated 30 July 2026.